Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Droz

Showing results (21-30 of 364) with videos related to

Pageof 37
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Optimal management of residual mass after chemotherapy in advanced seminoma: there is time for everythingS Culine, J P Droz
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 1, 2000
[Germ cell tumors of the testes: state of the art]A Fléchon, J P Droz
Revue Des Maladies Respiratoires|January 1, 1992
[Mediastinal seminoma. Is it an entity to be treated differently?]P Ruffié, J P Droz
Revue Des Maladies Respiratoires|January 1, 1992
[Germinal tumors of the mediastinum. Therapeutic strategy, prognosis, biology]J P Droz, P Ruffié
Expert Opinion on Investigational Drugs|July 5, 2005
New prospects for the treatment of germ-cell tumoursJ P Droz, S Culine
Pathologie-Biologie|January 1, 1993
[Use of G-CSF in chemotherapy of urogenital cancers]J P Droz, C Théodore
Bulletin Du Cancer|December 1, 1995
[Future trends in chemotherapy and impact on the management of emesis]G Catimel, J P Droz
Drug Safety|June 1, 2000
Comparative tolerability of chemotherapy regimens for germ cell cancerS Culine, J P Droz
Bulletin Du Cancer|October 18, 2001
[Is still there an indication for high-dose chemotherapy with hematopoietic stem-cell support in the treatment of germ-cell tumors?]A Fléchon, J P Droz
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
High-dose chemotherapy in tumours other than lymphomas and breast cancerJ P Droz, P Biron
Pageof 37

Showing results (21-30 of 364) with videos related to

Sort By:
Pageof 37
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Optimal management of residual mass after chemotherapy in advanced seminoma: there is time for everythingS Culine, J P Droz
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 1, 2000
[Germ cell tumors of the testes: state of the art]A Fléchon, J P Droz
Revue Des Maladies Respiratoires|January 1, 1992
[Mediastinal seminoma. Is it an entity to be treated differently?]P Ruffié, J P Droz
Revue Des Maladies Respiratoires|January 1, 1992
[Germinal tumors of the mediastinum. Therapeutic strategy, prognosis, biology]J P Droz, P Ruffié
Expert Opinion on Investigational Drugs|July 5, 2005
New prospects for the treatment of germ-cell tumoursJ P Droz, S Culine
Pathologie-Biologie|January 1, 1993
[Use of G-CSF in chemotherapy of urogenital cancers]J P Droz, C Théodore
Bulletin Du Cancer|December 1, 1995
[Future trends in chemotherapy and impact on the management of emesis]G Catimel, J P Droz
Drug Safety|June 1, 2000
Comparative tolerability of chemotherapy regimens for germ cell cancerS Culine, J P Droz
Bulletin Du Cancer|October 18, 2001
[Is still there an indication for high-dose chemotherapy with hematopoietic stem-cell support in the treatment of germ-cell tumors?]A Fléchon, J P Droz
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
High-dose chemotherapy in tumours other than lymphomas and breast cancerJ P Droz, P Biron
Pageof 37